The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies

The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies

The two oncogenic human gammaherpesviruses Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV) cause significant disease burden, particularly in immunosuppressed individuals. Both viruses display latent and lytic phases of their life cycle with different outcomes for their as...

Full description

Bibliographic Details
Main Authors:	Prishanta Chinna, Katrin Bratl, Humaira Lambarey, Melissa J. Blumenthal, Georgia Schäfer
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	International Journal of Molecular Sciences
Subjects:	Epstein-Barr virus (EBV or HHV-4) Kaposi’s sarcoma-associated herpesvirus (KSHV or HHV-8) human immunodeficiency virus (HIV) <i>Mycobacterium tuberculosis</i> (Mtb) <i>Plasmodium falciparum</i> severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Online Access:	https://www.mdpi.com/1422-0067/24/17/13066

Similar Items

Dangerous Liaisons: Gammaherpesvirus Subversion of the Immunoglobulin Repertoire
by: Monika A. Zelazowska, et al.
Published: (2020-07-01)

Tissue specific signature of HHV-6 infection in ME/CFS
by: Francesca Kasimir, et al.
Published: (2022-12-01)

A pentameric protein ring with novel architecture is required for herpesviral packaging
by: Allison L Didychuk, et al.
Published: (2021-02-01)

Diagnostic Value of Whole-Blood and Plasma Samples in Epstein–Barr Virus Infections
by: Mateusz Rzepka, et al.
Published: (2023-01-01)

Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections
by: Christian Münz
Published: (2023-12-01)

Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses
by: Luisa Galati, et al.
Published: (2024-03-01)

Telomeres and Viruses: Common Themes of Genome Maintenance
by: Zhong eDeng, et al.
Published: (2012-12-01)

Insights into the interplay between Epstein‐Barr virus (EBV) and multiple sclerosis (MS): A state‐of‐the‐art review and implications for vaccine development
by: Mahtab Mohammadzamani, et al.
Published: (2024-02-01)

Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
by: Jonas Blomberg, et al.
Published: (2019-08-01)

Natural Killer Cell Responses during Human γ-Herpesvirus Infections
by: Christian Münz
Published: (2021-06-01)

Epstein–Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992–2008
by: Katherine R. Sabourin, et al.
Published: (2023-09-01)

Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections
by: Enrique Fuentes-Mattei, et al.
Published: (2017-06-01)

KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection
by: Nicole Caduff, et al.
Published: (2021-05-01)

Viral Infection and Autophagy Dysregulation: The Case of HHV-6, EBV and KSHV
by: Maria Anele Romeo, et al.
Published: (2020-12-01)

Epstein–Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients
by: Bailey Brooks, et al.
Published: (2022-08-01)

Dendritic cells: Key players in human herpesvirus 8 infection and pathogenesis
by: Diana M. Campbell, et al.
Published: (2014-08-01)

The ubiquitin system and Kaposi’s sarcoma-associated herpesvirus
by: Akira eAshizawa, et al.
Published: (2012-02-01)

Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease
by: Nader Kim El-Mallawany, et al.
Published: (2018-11-01)

Emerging Themes from EBV and KSHV microRNA Targets
by: Dhivya Ramalingam, et al.
Published: (2012-09-01)

HERQ-9 Is a New Multiplex PCR for Differentiation and Quantification of All Nine Human Herpesviruses
by: Lari Pyöriä, et al.
Published: (2020-06-01)

Nanotechnology Frontiers in γ-Herpesviruses Treatments
by: Marisa Granato
Published: (2021-10-01)

Endemic Kaposi’s Sarcoma
by: Perla El Zeinaty, et al.
Published: (2023-01-01)

CDK4/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules
by: Yiquan Wu, et al.
Published: (2022-05-01)

Long Non-coding RNAs in Gammaherpesvirus Infections: Their Roles in Tumorigenic Mechanisms
by: Wen Liu, et al.
Published: (2021-01-01)

Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi’s Sarcoma Patients in South Africa
by: Rebecca Monica Tibenderana, et al.
Published: (2024-01-01)

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
by: Aude Jary, et al.
Published: (2021-12-01)

Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation
by: Deeksha Tiwari, et al.
Published: (2022-01-01)

Kaposi's sarcoma-associated herpesvirus at 27
by: Marta Maria Gaglia
Published: (2021-12-01)

IL-21 signaling promotes the establishment of KSHV infection in human tonsil lymphocytes by increasing differentiation and targeting of plasma cells
by: Nedaa Alomari, et al.
Published: (2022-12-01)

Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers—A Focus on EBV and KSHV Life Cycles and Carcinogenesis
by: Sherif T. S. Hassan, et al.
Published: (2022-12-01)

Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses
by: Christian Münz
Published: (2021-05-01)

Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study
by: Ruff Paul, et al.
Published: (2003-09-01)

Thymus capitatus flavonoids inhibit infection of Kaposi's sarcoma‐associated herpesvirus
by: Marwa Mekni‐Toujani, et al.
Published: (2022-06-01)

Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice
by: Patrick Schuhmachers, et al.
Published: (2021-03-01)

Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections
by: Yuan-Chuan Chen, et al.
Published: (2018-05-01)

Elevated iNOS and 3′-nitrotyrosine in Kaposi's Sarcoma tumors and mouse model
by: Olga Vladimirova, et al.
Published: (2023-06-01)

Herpesvirus Screening in Childhood Hematopoietic Transplant Reveals High Systemic Inflammation in Episodes of Multiple Viral Detection and an EBV Association with Elevated IL-1β, IL-8 and Graft-Versus-Host Disease
by: Moisés H. Rojas-Rechy, et al.
Published: (2022-08-01)

Immunoinformatics guided design of a next generation epitope-based vaccine against Kaposi Sarcoma
by: Hammadul Hoque, et al.
Published: (2022-01-01)

Reactivation and Lytic Replication of Kaposi’s Sarcoma-Associated Herpesvirus: An Update
by: Yan Yuan, et al.
Published: (2017-04-01)

Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections
by: Marta Maria Gaglia
Published: (2021-11-01)